[ad_1]
HEALTH
The objective is to vaccinate children aged 12 months to children under 5 years of age
The Municipal Health Secretariat (Sesau) of Campo Grande organizes from August 6 to 31 the Campaign of vaccination against polio and measles, to vaccinate 12-month-old children to children under 5 years (4 years, 11 months and 29 days). The goal is to vaccinate at least 95% of children in this age group and action was planned in the schedule of the Ministry of Health.
The campaign aims to recruit children who have not yet been vaccinated or who have not responded immunologically and therefore reduce or eliminate the pockets of the unvaccinated. Vaccination against adult measles will not be performed and D-Day is scheduled for August 18th.
Parents and caregivers are important social actors in the process of maintaining the elimination of immunopressible diseases and therefore should attend the units. (UBS / UBSF) with their children, taking the vaccination card for evaluation and registration of the vaccine. Unit vaccination rooms will be open from Monday to Friday, from 19:15 to 23:00 and from 13:00 to 16:45
VOP (oral vaccine – droplet) will be used against polio in children who have already received one or more doses of VIP (inactivated poliomyelitis – injectable vaccine) or OPV, regardless of the interval between the dose of the routine and to be administered in the campaign. The VIP will be administered to children who have not yet been vaccinated.
The measles virus is already used against measles, which protects against measles, mumps and rubella. For this vaccine, certain specific determinations of the Ministry of Health will be followed:
Will be vaccinated: children who have not been vaccinated; or who have received the vaccine for more than 30 days;
They will not be vaccinated: children who have received the Triple Viral vaccine or Tetra Viral (measles, mumps, rubella and chickenpox) for less than 30 days.
There are no absolute contraindications for VOP (droplets) and VIP, avoiding vaccination in children with acute infections and with fever above 38ºC; with known hypersensitivity to any of the components of the vaccine (streptomycin or erythromycin); or who have had an abnormal reaction to the vaccine in the past.
In the case of Viral Triple, the administration of this vaccine should be postponed in the following situations: moderate or severe acute febrile illnesses; after use of immunoglobulins, blood and derivatives; children on immunosuppressive or biological therapy; the use of corticosteroids at immunosuppressive doses; in use of antineoplastic chemotherapy should only be vaccinated 3 months after stopping treatment; It is recommended that recipients of bone marrow transplants be vaccinated at intervals of 12 to 24 months after transplantation for the first dose. The vaccine is contraindicated in case of anaphylaxis (severe allergy) at the previous dose of the vaccine; or in children under 5 with severe immunosuppression.
Immunization coverage
Up to June of this year 6756 children were vaccinated with Triple Viral, reaching a vaccination coverage of 95.14%, while in the VIP, 5403 children received the 3rd dose representing 76.09% of the goal. In 2017, coverage was 96.44% and 83.02%, respectively.
Poliomyelitis
With regard to polio, it is a contagious viral infectious disease. acute, characterized by flaccid paralysis of sudden onset. It usually affects the lower limbs, asymmetrically, having as main features muscle flaccidity, with preserved sensitivity, and arréflexie in the affected segment. Transmission occurs through direct person-to-person contact, by the fecal-oral route (most often), by objects, food and water contaminated with stool from patients or carriers, or by oral-oral by droplets of oropharyngeal secretions. speak, cough or sneeze).
Measles
Measles is an infectious infectious infectious disease, transmissible and extremely contagious, with high prevalence of infection, being able to evolve with complications and death, especially in malnourished children and less than one year old. Transmission occurs from one person to another, through respiratory secretions, within four to six days before the onset of eruption until four days later. The last case of the disease recorded at Campo Grande was in 2002.
[ad_2]
Source link
